Literature DB >> 18303744

Clean intermitent catheterisation in the management of urethral strictures.

P M Ngugi1, A Kassim.   

Abstract

OBJECTIVE: To compare clean intermittent self-catheterisation and urethral dilatation with sounds in the management of recurrent urethral strictures.
DESIGN: A prospective randomised control trial between repeated urethral dilatation with sounds and use of clean intermittent self-catheterisation in the management of recurrent urethral strictures.
SETTING: Kenyatta National Hospital, urology clinics.
SUBJECTS: Forty nine patients with recurrent urethral strictures were randomised between clean intermittent catheterisation (CISC) and urethral dilatation with sounds.
RESULTS: The urinary flow rates were better in patients on the CISC arm compared to the dilatation arm. Seventy three percent of patients having clutton sounds dilatation developed urinary tract infections compared to 25% of those on CISC. The patients in the CISC arm had a uniformly higher quality of life score than those having sounds dilatation of the urethra.
CONCLUSION: Clean intermittent self-catheterisation is an effective and safe way of managing recurrent urethral strictures. It is a better method than repeated clutton sounds dilatation.

Entities:  

Mesh:

Year:  2007        PMID: 18303744     DOI: 10.4314/eamj.v84i11.9571

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  Long-term management of luminal urethral stricture in women.

Authors:  Shreeya Popat; Philippe E Zimmern
Journal:  Int Urogynecol J       Date:  2016-03-30       Impact factor: 2.894

2.  Female Urethral Reconstruction.

Authors:  Anne L Ackerman; Jerry Blaivas; Jennifer T Anger
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-10-19

3.  Bipolar plasma vaporization using plasma-cutting and plasma-loop electrodes versus cold-knife transurethral incision for the treatment of posterior urethral stricture: a prospective, randomized study.

Authors:  Wansong Cai; Zhiyuan Chen; Liping Wen; Xiangxin Jiang; Xiuheng Liu
Journal:  Clinics (Sao Paulo)       Date:  2016-01       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.